VEGF-A drugs for Diabetic Macular Edema

12 tracked VEGF-A drugs in the Diabetic Macular Edema race. The class explanation lives on the VEGF-A page; the full indication pipeline across every mechanism is on the Diabetic Macular Edema page.

12 approved / phase 4

Head-to-head evidence: Aflibercept vs Brolucizumab-Dbll · Brolucizumab-Dbll vs Ranibizumab · aflibercept-abzv (Enzeevu) vs Brolucizumab-Dbll · aflibercept-ayyh (Pavblu) vs Brolucizumab-Dbll · aflibercept-boav (Eydenzelt) vs Brolucizumab-Dbll · aflibercept-jbvf (Yesafili) vs Brolucizumab-Dbll

The roster

← all VEGF-A drugs